Abstract
During the last decade the nanotechnologists began research on applications of nanomaterials for medicine and therapeutics. Various nanoparticles (nanomedicines) are being used worldwide for the diagnosis and management in a number of disorders including cancer and neurodegenerative disorders. The successful non-viral gene therapy is now possible with the advancements in nanotechnology. Mostly nanoparticles are divided into two main classes: organic and inorganic nanoparticles. Diverse features of nanomedicines with surface modification help to make them biocompatible with addition of varying polymer that facilitates targeted delivery of drug and its controlled release into the cells, tissues and organs. Liposomes, quantum dots, silver and gold nanoparticles are the most common examples of nanomedicines.
Keywords: Cancer, gene therapy¸ liposomes, nanomedicines, neurodegenerative disorders, quantum dots, silver and gold nanoparticles.
Current Drug Metabolism
Title:Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties
Volume: 16 Issue: 5
Author(s): Mahmood Rasool, Muhammad Imran Naseer, Arif Malik, Abdul Manan, Ikram Ullah, Noman Bin Abid, Myeong Ok Kim, Mahmood Husain Qazi, Mohammad Amjad Kamal and Fehmida Bibi
Affiliation:
Keywords: Cancer, gene therapy¸ liposomes, nanomedicines, neurodegenerative disorders, quantum dots, silver and gold nanoparticles.
Abstract: During the last decade the nanotechnologists began research on applications of nanomaterials for medicine and therapeutics. Various nanoparticles (nanomedicines) are being used worldwide for the diagnosis and management in a number of disorders including cancer and neurodegenerative disorders. The successful non-viral gene therapy is now possible with the advancements in nanotechnology. Mostly nanoparticles are divided into two main classes: organic and inorganic nanoparticles. Diverse features of nanomedicines with surface modification help to make them biocompatible with addition of varying polymer that facilitates targeted delivery of drug and its controlled release into the cells, tissues and organs. Liposomes, quantum dots, silver and gold nanoparticles are the most common examples of nanomedicines.
Export Options
About this article
Cite this article as:
Rasool Mahmood, Imran Naseer Muhammad, Malik Arif, Manan Abdul, Ullah Ikram, Bin Abid Noman, Ok Kim Myeong, Husain Qazi Mahmood, Amjad Kamal Mohammad and Bibi Fehmida, Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties, Current Drug Metabolism 2015; 16 (5) . https://dx.doi.org/10.2174/1389200215666141125121211
DOI https://dx.doi.org/10.2174/1389200215666141125121211 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Glance Over the Cannabinoid Machinery to Design New Anti- Angiogenic Compounds
Mini-Reviews in Medicinal Chemistry Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells
Mini-Reviews in Medicinal Chemistry The Implications of Autophagy in Alzheimer’s Disease
Current Alzheimer Research The Neuroprotective Role of Vesicular Monoamine Transporter 2 in Neurodegenerative Diseases
Medicinal Chemistry Potential Phytotherapeutic Approaches for the Treatment of Alzheimer’s Disease: An Overview
Current Traditional Medicine New Perspectives on Machine Learning in Drug Discovery
Current Medicinal Chemistry Adipose Tissue Derived Stem Cells Secretome: Soluble Factors and Their Roles in Regenerative Medicine
Current Stem Cell Research & Therapy Meet Our Editorial Board Member
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimers Disease, Depression, and Parkinsons Disease
Current Bioactive Compounds Involvement of the Endocannabinoid System in Motor Disorders
Current Medicinal Chemistry - Central Nervous System Agents Cannabinoids: Occurrence and Medicinal Chemistry
Current Medicinal Chemistry Neurotransmitters and Microglial-Mediated Neuroinflammation
Current Protein & Peptide Science Adult Neurogenesis and the Diseased Brain
Current Medicinal Chemistry Liposomes as siRNA Delivery Vectors
Current Drug Metabolism Significance of High Levels of Endogenous Melatonin in Mammalian Cerebrospinal Fluid and in the Central Nervous System
Current Neuropharmacology Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Permeating the Blood Brain Barrier and Abrogating the Inflammation in Stroke: Implications for Stroke Therapy
Current Pharmaceutical Design Molecular Mechanisms Determining Opposed Functional States of Microglia
Current Neuropharmacology Autophagy after Subarachnoid Hemorrhage: Can Cell Death be Good?
Current Neuropharmacology The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research